{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:26Z","timestamp":1794047486663,"version":"4.8.0"},"reference-count":15,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"1","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2024.286124","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T02:43:47Z","timestamp":1726109027000},"page":"244-250","source":"Crossref","is-referenced-by-count":2,"title":["A phase I study of MAGE-A1-targeted T1367 T-cell receptorbased cell therapy in patients with advanced multiple myeloma"],"prefix":"10.3324","volume":"110","author":[{"given":"Josefine","family":"Kr\u00fcger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Obenaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor Wolfgang","family":"Blau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Hoser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Vaegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Rauschenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Anagnostopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korinna","family":"J\u00f6hrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Scheuplein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Kieback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"B\u00f6hme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Christin","family":"Von Br\u00fcnneck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kr\u00f6nke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Busse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Willimsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Blankenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pezzutto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Nogai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"key":"71268","doi-asserted-by":"crossref","unstructured":"Yang P, Meng M, Zhou Q. Oncogenic cancer\/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy. Biochim Biophys Acta Rev Cancer. 2021; 1876(1):188558.","DOI":"10.1016\/j.bbcan.2021.188558"},{"key":"71269","doi-asserted-by":"crossref","unstructured":"van der Bruggen P, Traversari C, Chomez P. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 1991; 254(5038):1643-1647.","DOI":"10.1126\/science.1840703"},{"key":"71270","unstructured":"Dhodapkar MV, Osman K, Teruya-Feldstein J. Expression of cancer\/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease. Cancer Immun. 2003; 3:9."},{"key":"71271","doi-asserted-by":"crossref","unstructured":"Chari A, Cho HJ, Dhadwal A. A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma. Blood Adv. 2017; 1(19):1575-1583.","DOI":"10.1182\/bloodadvances.2017007427"},{"key":"71272","doi-asserted-by":"crossref","unstructured":"Holstein SA, Grant SJ, Wildes TM. Chimeric antigen receptor T-cell and bispecific antibody therapy in multiple myeloma: moving into the future. J Clin Oncol. 2023; 41(27):4416-4429.","DOI":"10.1200\/JCO.23.00512"},{"key":"71273","doi-asserted-by":"crossref","unstructured":"Lee H, Ahn S, Maity R. Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myeloma. Nat Med. 2023; 29(9):2295-2306.","DOI":"10.1038\/s41591-023-02491-5"},{"key":"71274","doi-asserted-by":"crossref","unstructured":"Rapoport AP, Stadtmauer EA, Binder-Scholl GK. NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma. Nat Med. 2015; 21(8):914-921.","DOI":"10.1038\/nm.3910"},{"key":"71275","doi-asserted-by":"crossref","unstructured":"Salter AI, Rajan A, Kennedy JJ. Comparative analysis of TCR and CAR signaling informs CAR designs with superior antigen sensitivity and in vivo function. Sci Signal. 2021; 14(697):eabe2606.","DOI":"10.1126\/scisignal.abe2606"},{"key":"71276","doi-asserted-by":"crossref","unstructured":"Teppert K, Wang X, Anders K, Evaristo C, Lock D, K\u00fcnkele A. Joining forces for cancer treatment: rrom \u201cTCR versus CAR\u201d to \u201cTCR and CAR\u201d. Int J Mol Sci. 2022; 23(23):14563.","DOI":"10.3390\/ijms232314563"},{"key":"71277","doi-asserted-by":"crossref","unstructured":"Obenaus M, Leit\u00e3o C, Leisegang M. Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice. Nat Biotechnol. 2015; 33(4):402-407.","DOI":"10.1038\/nbt.3147"},{"key":"71278","doi-asserted-by":"crossref","unstructured":"D\u2019Agostino M, Cairns DA, Lahuerta JJ. Second revision of the International Staging System (R2-ISS) for overall survival in multiple myeloma: a European Myeloma Network (EMN) report within the HARMONY project. J Clin Oncol. 2022; 40(29):3406-3418.","DOI":"10.1200\/JCO.22.02228"},{"key":"71279","doi-asserted-by":"crossref","unstructured":"Palumbo A, Avet-Loiseau H, Oliva S. Revised International Staging System for multiple myeloma: a report from International Myeloma Working Group. J Clin Oncol. 2015; 33(26):2863-2869.","DOI":"10.1200\/JCO.2015.61.2267"},{"key":"71280","unstructured":"National Cancer Institute. Common terminology criteria for adverse events (CTCAE) Version 4.0. 2024."},{"key":"71281","unstructured":"Kumar S, Paiva B, Anderson KC. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2016; 17(8):e328-e346."},{"key":"71282","doi-asserted-by":"crossref","unstructured":"Adebayo OO, Dammer EB, Dill CD. Multivariant transcriptome analysis identifies modules and hub genes associated with poor outcomes in newly diagnosed multiple myeloma patients. Cancers (Basel). 2022; 14(9):2228.","DOI":"10.3390\/cancers14092228"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.286124\/77496","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.286124\/77962","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11756\/77496","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:07:18Z","timestamp":1794046038000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2024.286124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2024.286124","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,12]]}}}